Friday, October 21, 2011

A New Nasal Delivery Method For the Masses?

Could this simple new nasal technology become more popular than the conventional nasal spray pump and even invasive injectibles for the delivery of numerous medications? The inventor says yes, mainly since the device has the natural ability to increase nasal residence time of a given medication or agent to such a large extent. It is well known that medications sprayed into the nasal cavity via conventional methods are rapidly cleared from the nasal cavity into the digestive tract where up to 90% of the medication is un-absorbed and wasted. This is highly inefficient and toxic to the digestive tract. Instead, this technology physically would hold a given medication or agent in place against the nasal mucosa for hours at a time. The inventor suggests the rate of delivery can be controlled in various ways and that it's elementary that this approach will allow for reduced dose size with increased drug bio-absorption. The technology also promises a number of other key safety and efficiency benefits.

Since the device does the opposite of 'flooding' medications into the body, such as with injections and the common spray technologies, it can offer less risk to the patient. With vaccines and other pharmaceuticals, the technology would slowly administer these powerful medications over a much longer period of time. Thus, if there were any indications in the patient that the medication was causing irritation or an adverse reaction, further drug flow could instantly be halted in contrast to present technology. "With vaccines, why have your child play a game of roulette", says the inventor.

The technology offers applications as a general medical disposable using anti-microbial compounds like nano-colloidal silver or (CHG) that healthcare staff could arm themselves with in the healthcare environment. The FDA has classified the technology as a non-medical device exempt from regulation and the inventor is seeking U.S. partners in the medical field.

For more information visit the product website and contact Mr. Dave Foggia, also the author of this post.

No comments:

Post a Comment